United States National Library of Medicine

News and Video Search Results

News coverage

Novartis Phase III Beovu® data show potential for fluid resolution in more diabetic macular edema patients with fewer injections versus aflibercept

GlobeNewswire 01 May 2021

· In KESTREL and KITE, Beovu (brolucizumab) 6 mg met the primary endpoints of non-inferiority in change in best corrected visual..

Vitamin D Therapy Market Value Predicted To Reach US$ 3,819.4 Million By 2027: Acumen Research And Consulting
GlobeNewswire 25 Mar 2021
Chronic Wound Care Market Size 2021 | To Reach USD 16.36 Billion with 6.2% by 2027; Increasing Investment in Technological Integration will Emerge in Favor of Market Growth, says Fortune Business Insights™
GlobeNewswire 25 Mar 2021
New Zolgensma data demonstrate age-appropriate development when used early, real-world benefit in older children and durability 5+ years post-treatment
GlobeNewswire 15 Mar 2021
Novartis provides update on Phase III study evaluating canakinumab (ACZ885) as second or third-line treatment in combination with chemotherapy in non-small cell lung cancer
GlobeNewswire 09 Mar 2021

0 shares 1 views

United States National Library of Medicine media coverage

Delving Into Functional Adult Literacy (FAL) – Analysis

Delving Into Functional Adult Literacy (FAL) – Analysis

Eurasia Review 04 Mar 2021

The World Declaration on Education for All (March 5-9, 1990) (1) clearly stated that everyone should have the opportunity for..

Advertisement

More coverage

Angle PLC - Parsortix Demonstrates High Capture Rate of CTCs

Angle PLC - Parsortix Demonstrates High Capture Rate of CTCs

Accesswire 29 Jan 2021

*MAJOR EUROPEAN CONSORTIUM PUBLISHES RESULTS OF LARGE-SCALE INVESTIGATION DEMONSTRATING KEY ADVANTAGES OF PARSORTIX SYSTEM IN LUNG..

Gene Therapy Leader Katherine High Joins AskBio as President, Therapeutics
GlobeNewswire 12 Jan 2021
Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene
GlobeNewswire 11 Jan 2021
World Human Gene Sequencing Markets, Strategies & Trends Report 2021-2025: A Crowded, Growing Global Market with Complicated Packaging and Pricing is Emerging with Unlimited Growth Opportunities
GlobeNewswire 15 Dec 2020
Novartis reports positive topline results from second Phase III trial of Beovu® in patients with diabetic macular edema
GlobeNewswire 15 Dec 2020

Explore